PUMA BIOTECHNOLOGY, INC.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 10880 WILSHIRE BLVD., LOS ANGELES, CA, 90024
Mailing Address 10880 WILSHIRE BLVD., LOS ANGELES, CA, 90024
Phone (424) 248-6500
Fiscal Year End 1231
EIN 770683487
Financial Overview
FY2024
$30.28M
Net Income
$230.53M
Total Assets
$0.62
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | January 8, 2026 | View on SEC |
| 4 Insider stock transaction report | January 8, 2026 | View on SEC |
| 4 Insider stock transaction report | January 8, 2026 | View on SEC |
| 4 Insider stock transaction report | November 13, 2025 | View on SEC |
| 8-K Current report of material events | November 6, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 6, 2025 | View on SEC |
| 8-K Current report of material events | August 7, 2025 | View on SEC |
| 10-Q/A Quarterly report amendment | August 7, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 7, 2025 | View on SEC |
| 4 Insider stock transaction report | July 22, 2025 | View on SEC |
Insider Trading
SELL 3 insiders
6 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.